Sample preparation prior to the LC––MS-based metabolomics/metabonomics of blood-derived samples. (July 2011)

• Record Type: Journal Article
• Authors: Gika, Helen; Theodoridis, Georgios
• Is Part Of: Bioanalysis. Volume 3:Number 14(2011)
• Page Start: 1647
• Page End: 1661
• Publication Date: 2011-07
• Subjects: Drugs -- Analysis -- Periodicals; 615.19005
• DOI: 10.4155/bio.11.122
• Languages: English
• ISSNs: 1757-6180

Abstract

Blood represents a very important biological fluid and has been the target of continuous and extensive research for diagnostic, or health and drug monitoring reasons. Recently, metabonomics/metabolomics have emerged as a new and promising ''omics'' platform that shows potential in biomarker discovery, especially in areas such as disease diagnosis, assessment of drug efficacy or toxicity. Blood is collected in various establishments in conditions that are not standardized. Next, the samples are prepared and analyzed using different methodologies or tools. When targeted analysis of key molecules (e.g., a drug or its metabolite[s]) is the aim, enforcement of certain measures or additional analyses may correct and harmonize these discrepancies. In omics fields such as those performed by holistic analytical approaches, no such rules or tools are available. As a result, comparison or correlation of results or data fusion becomes impractical. However, it becomes evident that such obstacles should be overcome in the near future to allow for large-scale studies that involve the assaying of samples from hundreds of individuals. In this case the effect of sample handling and preparation becomes very serious, in order to avoid wasting months of work from experts and expensive instrument time. The present review aims to cover the different methodologies applied to the pretreatment of blood prior to LC––MS metabolomic/metabonomic studies. The article tries to critically compare the methods and highlight issues that need to be addressed.